v3.25.2
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Millions
Jun. 30, 2025
Dec. 31, 2024
Assets    
Cash and cash equivalents $ 122 $ 328
Restricted cash and cash equivalents (Note 16) 13 37
Accounts receivable (Note 3) 226 123
Inventory, net (Note 5) 224 302
Derivative instruments (Notes 2 and 11) 80 66
Other current assets 165 184
Total current assets 830 1,040
Property, plant and equipment, net (Note 7) 3,089 3,154
Nuclear decommissioning trust funds (Notes 6 and 11) 1,790 1,724
Derivative instruments (Notes 2 and 11) 0 5
Other noncurrent assets 118 183
Total Assets 5,827 6,106
Liabilities and Equity    
Revolving credit facilities (Notes 10 and 11) 70 0
Long-term debt, due within one year (Notes 10 and 11) 17 17
Accrued interest 30 18
Accounts payable and other accrued liabilities 226 266
Derivative instruments (Notes 2 and 11) 32 0
Other current liabilities 77 154
Total current liabilities 452 455
Long-term debt (Notes 10 and 11) 2,972 2,987
Derivative instruments (Notes 2 and 11) 62 7
Postretirement benefit obligations 282 305
Asset retirement obligations and accrued environmental costs (Note 8) 478 468
Deferred income taxes 297 362
Other noncurrent liabilities 38 135
Total Liabilities 4,581 4,719
Commitments and Contingencies (Note 9)
Stockholders' Equity (Note 15)    
Common stock [1] 0 0
Additional paid-in capital 1,711 1,725
Accumulated retained earnings (deficit) (456) (326)
Accumulated other comprehensive income (loss) (9) (12)
Total Stockholders' Equity 1,246 1,387
Total Liabilities and Stockholders' Equity $ 5,827 $ 6,106
[1]
(a)45,659,227 and 45,961,910 shares issued and outstanding as of June 30, 2025 and December 31, 2024, respectively.